The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preclinical and early clinical data of ZN-1041 in combination with trastuzumab deruxtecan to treat breast cancer with or without CNS metastases.
 
Carey K. Anders
Honoraria - AstraZeneca; Athenex; Eisai; Elucida Oncology; Genentech/Roche; Immunomedics; IPSEN; Novartis; Puma Biotechnology; Seagen
Consulting or Advisory Role - AstraZeneca; Athenex; Eisai; Elucida Oncology; Genentech/Roche; Immunomedics; Ipsen; Seagen
Research Funding - AstraZeneca (Inst); Caris Life Sciences (Inst); Elucida Oncology (Inst); G1 Therapeutics (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Seagen (Inst); Tesaro (Inst); Zion Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Jones and Bartlett; Up to Date.com
Travel, Accommodations, Expenses - Eisai
 
Nancy U. Lin
Stock and Other Ownership Interests - Artera
Consulting or Advisory Role - Affinia Therapeutics; Aleta Biotherapeutics; Artera; AstraZeneca; Blueprint Medicines; Daiichi Sankyo; Denali Therapeutics; Johnson & Johnson/Janssen; Olema Pharmaceuticals; Pfizer; Prelude Therapeutics; Puma Biotechnology; Seagen; Voyager Therapeutics
Research Funding - Genentech (Inst); Merck (Inst); Olema Pharmaceuticals (Inst); Pfizer (Inst); Seagen (Inst); Zion Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Royalties for chapter in Up-to-Date regarding management of breast cancer brain metastases; Royalties, Jones & Bartlett
 
Aarti Chand
Consulting or Advisory Role - Novartis; Sanofi
Research Funding - Abbvie (Inst); I-Mab (Inst); Incyte (Inst); Sanofi (Inst); Zion Pharma (Inst)
 
Tingting Fu
Employment - Suzhou Zanrong Pharma
 
Di Zhu
Employment - Suzhou Zanrong Pharma
 
Zheng Wang
Employment - Suzhou Zanrong Pharma
 
Ding Zhou
Employment - Suzhou Zanrong Pharma
Leadership - Suzhou Zanrong Pharma
Stock and Other Ownership Interests - Suzhou Zanrong Pharma
Patents, Royalties, Other Intellectual Property - Suzhou Zanrong Pharma
 
Ziqiang (Zack) Cheng
Employment - Suzhou Zanrong Pharma
Leadership - Suzhou Zanrong Pharma
Stock and Other Ownership Interests - Suzhou Zanrong Pharma
Patents, Royalties, Other Intellectual Property - Suzhou Zanrong Pharma